Contract Notice Detail
Summary Information
Summary Information
Forbid offers above base price:
Request Reference:
31/4849/2021
Request Name:
Medicamentos Bictegravir 50 mg + Emtricitabina 200 mg + Tenofovir alafenamida 25 mg Comp
Phase:
Tendering Phase
State:
Awarded
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG; CÁP/ COMP]
4
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Faro PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
10/22/2021 1:42 PM
(UTC +1 hour)
National official publishing date and time (DR):
5/10/2019 12:00 AM
(UTC +1 hour)
Due datetime for receiving replies:
10/25/2021 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
31000048492021.xlsx
31000048492021.xlsx
Download
convite 258º.pdf
convite 258º.pdf
Download
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Lote 1
Section for Lot - B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG; CÁP/ COMP]
1.1.1
Lote 1
Bill of Quantities
*
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
Preço Total
Total without VAT
0,000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
B712
Internal Reference
Description
BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG; CÁP/ COMP]
Qty
16.200,000000
Unit
UN
Price per Unit
Total
Comentários do Comprador:
503604704 | Gilead Sciences, Lda. | CPA:2019040/229/0081 | NºAIM:5753645;
Evaluation
Evaluation
Evaluation General Settings
Evaluation General Settings
Evaluation guideline
MostEconomicallyAdvantageousTender
Evaluation Method
Manual
Evaluation Items
Evaluation Items
Name
Lot
Regras de avaliação para o lote 1
1 - B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG; CÁP/ COMP]
Critérios de Adjudicação
Peso (%)**
1
Preço
100
Define tie breaking rules?
Yes
No
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...